Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.
about
The Galectin-9/Tim-3 pathway is involved in the regulation of NK cell function at the maternal-fetal interface in early pregnancyUp-regulation of galectin-9 induces cell migration in human dendritic cells infected with dengue virusGalectin-9 enhances cytokine secretion, but suppresses survival and degranulation, in human mast cell lineRole of Tim-3 in hepatitis B virus infection: An overviewBeyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint RegulatorsGalectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell responseTumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1Galectins: regulators of acute and chronic inflammationTim-3 directly enhances CD8 T cell responses to acute Listeria monocytogenes infectionGalectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cellsThe epithelial polarity regulator LGALS9/galectin-9 induces fatal frustrated autophagy in KRAS mutant colon carcinoma that depends on elevated basal autophagic fluxGalectin-9 prolongs the survival of septic mice by expanding Tim-3-expressing natural killer T cells and PDCA-1+ CD11c+ macrophagesRole of TIM-3 in ovarian cancer.Association of T-cell immunoglobulin and mucin domain-containing molecule 3 (Tim-3) polymorphisms with susceptibility and disease progression of HBV infection.Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers.Tim-3 expression defines regulatory T cells in human tumors.Galectin-9 activates and expands human T-helper 1 cells.TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines.Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemiaThe herpes simplex virus 1 latency-associated transcript promotes functional exhaustion of virus-specific CD8+ T cells in latently infected trigeminal ganglia: a novel immune evasion mechanismChallenges and future perspectives of T cell immunotherapy in cancerCooperative Interactions of Oligosaccharide and Peptide Moieties of a Glycopeptide Derived from IgE with Galectin-9.Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity.Reduced Expression of Galectin-9 Contributes to a Poor Outcome in Colon Cancer by Inhibiting NK Cell Chemotaxis Partially through the Rho/ROCK1 Signaling PathwayGalectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infectionHuman Galectin-9 Is a Potent Mediator of HIV Transcription and ReactivationAllograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.Preparation and characterization of a novel nanobody against T-cell immunoglobulin and mucin-3 (TIM-3).Cell surface galectin-9 expressing Th cells regulate Th17 and Foxp3+ Treg development by galectin-9 secretionImmunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation.The uncertain role of unmodified mesenchymal stem cells in tumor progression: what master switch?Tumor-induced disruption of proximal TCR-mediated signal transduction in tumor-infiltrating CD8+ lymphocytes inactivates antitumor effector phaseGalectin-9 signaling through TIM-3 is involved in neutrophil-mediated Gram-negative bacterial killing: an effect abrogated within the cystic fibrosis lung.TIM-3 is not essential for development of airway inflammation induced by house dust mite antigens.Tim-3: an activation marker and activation limiter of innate immune cellsCostimulatory pathways in transplantation: challenges and new developments.Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settings.T cell Ig and mucin domain proteins and immunity.Lectin-based structural glycomics: a practical approach to complex glycans.
P2860
Q24313559-3A9B70ED-8DFD-473F-9032-EE51A7A9524FQ24321941-6683BE9A-4F93-4137-ACF5-9A9FB17874D4Q24323267-CD12F331-9D37-4200-A527-4BF54A503978Q26768530-ED5F03D9-8C9F-493E-AD0D-E125DD704941Q26782799-449DD02D-D985-4A5E-9C4D-DB73ED299EA3Q27314881-0292FD0F-D9D5-42C8-BDCB-70588BF233D3Q28116224-C5054419-C391-4E02-A38E-494D58548EACQ28272886-DC1DB1E0-F5E9-406B-9F58-1A754D426289Q28506567-45DF3116-9AF7-4B24-B76F-E6B0AFBD4401Q28511684-8EAC9FEA-9444-476A-B215-835EC85027B8Q28607006-B16F5CC8-5B9F-4244-BCDB-0F15615E425CQ28658232-8F545CD5-C1F4-4DF4-99FB-A6C1CE32A1D2Q30235023-8CF03397-B880-40D6-89F4-CB569A49F1A2Q33670670-C7A4B9EA-F1AE-4C8E-8C9D-E32AFEF81E3BQ33828349-BCC794E6-6C2B-485D-A70B-7D2AC13A5DFDQ34634058-938815AA-D576-4F4E-A945-211AF6E9EBACQ34761415-59F770E9-686E-4B76-B15E-51F5142A3E1CQ34997144-B0B2E1F3-E2E7-4B25-BE0D-2B32C2B7BD0DQ34997704-6BEBBBDE-B2D0-4B4B-AC90-5FB075CD264AQ35193019-1EA21118-A59A-4595-A20A-031C7CFFCF48Q35843507-B43E62F1-2906-49EF-9DC8-CB13C77BBE4FQ35845788-4EAC6943-AF4F-44D4-BE31-8A4A6C657AF7Q35876978-E1FD9784-3DB9-44AC-B222-95706CAE8193Q35909663-71C2C9D2-C073-4B3C-942F-BAD84A60365EQ35974260-7EA7D0F3-E252-4B6E-A6C8-D78992AFEA59Q35986628-C2007D7D-FF0A-4A41-B20F-8D1FC0D56764Q36037844-5B7BCCB2-B96A-451C-A4FF-456505E7C6E8Q36068258-E75AB9EA-1F7E-4702-8C39-60127E87996DQ36213059-046901DF-E0AD-455B-85F3-B0EDC3563688Q36381148-9A9C9A0C-41D1-4877-B11C-A27A14386EADQ36985164-7D84E554-D9FD-41B4-8658-3A00CFB2973DQ36998634-9C4E8CF8-22DE-4A50-81D6-2FA35072FCFAQ37017472-6461B1FB-4B33-4565-8F8C-A76242A8F276Q37203240-A9089011-4C1A-4A30-9629-52522FAE3437Q37357538-8EFD48AE-B439-4BAA-833C-7304560B210FQ37379212-55F23349-5B04-4895-8310-0837E848C2F2Q37474958-028F6E6A-AEDB-42F9-BB85-34B278C20F76Q37656022-1F710891-10F7-485A-ACDC-30B2078BC0EBQ37702049-EE50185F-ACE1-4731-A42A-8C91DDE2BBACQ37872259-7B078BF0-E1BA-44BC-9218-4481597DAAF4
P2860
Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Galectin-9 increases Tim-3+ de ...... galectin-9-Tim-3 interactions.
@en
Galectin-9 increases Tim-3+ de ...... galectin-9-Tim-3 interactions.
@nl
type
label
Galectin-9 increases Tim-3+ de ...... galectin-9-Tim-3 interactions.
@en
Galectin-9 increases Tim-3+ de ...... galectin-9-Tim-3 interactions.
@nl
prefLabel
Galectin-9 increases Tim-3+ de ...... galectin-9-Tim-3 interactions.
@en
Galectin-9 increases Tim-3+ de ...... galectin-9-Tim-3 interactions.
@nl
P2093
P2860
P1476
Galectin-9 increases Tim-3+ de ...... galectin-9-Tim-3 interactions.
@en
P2093
Akira Yamauchi
Atsuya Nobumoto
Jun Hirabayashi
Keiichi Kontani
Keiko Nagahara
Kota Watanabe
Minoru Miyake
Mitsuomi Hirashima
Shigeki Katoh
Souichi Oomizu
P2860
P304
P356
10.4049/JIMMUNOL.181.11.7660
P407
P577
2008-12-01T00:00:00Z